Target intelligence / Profile preview

60S ribosomal protein L7a (RPL7A)

Target
RPL7A
Molecular classification
Ribosomal protein, Structural constituent of ribosome, L7AE family, Other
01

Overview

60S ribosomal protein L7a (RPL7A) is a key structural component of the large (60S) ribosomal subunit, belonging to the L7AE family of ribosomal proteins. It functions in the cytoplasm as part of the ribosome, catalyzing protein synthesis (translation). RPL7A contains two RNA-binding domains and participates directly in the assembly and functioning of ribonucleoprotein complexes. Beyond its structural roles, RPL7A can interact with a subset of nuclear hormone receptors, such as the thyroid hormone receptor, modulating their ability to activate gene transcription by blocking receptor-DNA binding. Expression of RPL7A can be altered in disease contexts—including upregulation and downregulation in breast cancer and osteosarcoma, respectively—suggesting roles in tumor progression and diagnosis. Gene rearrangement involving RPL7A and the trk proto-oncogene can result in oncogenic proteins. RPL7A is not a typical drug target, but it is of pathological and potential biomarker relevance in several diseases, notably certain cancers and genetic disorders.

Other names
L7aSURF3TRUPribosomal protein L7aLarge ribosomal subunit protein eL8PLA-X polypeptideSurfeit locus protein 3surfeit 3thyroid hormone receptor uncoupling proteineL8
02

Biological functions

Protein synthesis (translation)RNA bindingRibosome assemblyModulation of nuclear hormone receptor activityStructural constituent of ribosome
03

Disease associations

Cancer (role in tumor progression and metastasis)Charcot-Marie-Tooth disease, axonal, type 2NDiamond-Blackfan anemiaOther (modulation in breast cancer, osteosarcoma)
04

Biomarkers

Possible prognostic marker in osteosarcoma

Beyond the preview

Go deeper on 60S ribosomal protein L7a (RPL7A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 60S ribosomal protein L7a (RPL7A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call